Purchase Order W81K0020P0276
- Not listed
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, was awarded a delivery order valued at $108,657.52 by the Defense Health Agency for blood coagulation analyzer equipment and associated reagents. The contract is effective from October 1, 2025, through September 30, 2026, and carries a firm fixed-price structure with no small business set-aside designation. Performance will occur in Fayetteville, North Carolina. This delivery order likely...
- The Defense Health Agency awarded Werfen USA LLC a $686,054.81 firm fixed-price purchase order for coagulation testing services and supplies at Fort Liberty, North Carolina. The award, announced on August 17, 2020, follows the Army Medical Command's solicitation for reagents and automated analyzers to support ongoing coagulation testing requirements at the installation. Under the contract, Werfen USA LLC is responsible for providing all necessary personnel, equipment, maintenance,...
- The Defense Health Agency awarded a $430,739.50 firm fixed-price purchase order to Werfen USA LLC for reagents and analyzer cost-per-test equipment, effective through September 30, 2029. The contract, awarded on October 1, 2024, supports clinical laboratory diagnostic capabilities at the agency's healthcare facilities. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and consumables, will perform work at its Massachusetts location. This award...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts. The contract is for the supply of a blood coagulation analyzer and related reagents, with a ceiling value of $9,687.87 and a period of performance through July 31, 2025. Werfen USA LLC is a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care...
- The Defense Health Agency awarded a $20.2K delivery order to Werfen USA LLC on July 22, 2025, for the supply of in vitro diagnostic equipment and related medical laboratory products. The firm fixed-price contract, with an ultimate completion date of September 30, 2025, is issued under the General Services Administration Multiple Award Schedule and carries no small business set-aside designation. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer specializing in coagulation analyzers,...
- The Defense Health Agency awarded Werfen USA LLC a $362,185.95 firm fixed-price purchase order on September 1, 2024, for a Cost Per Reportable (CPR) automated coagulation system at David Grant Medical Center, Travis Air Force Base, California. The contract runs through August 31, 2029, with a base year from September 1, 2024, through August 31, 2025, followed by four 12-month option years. Under this solicitation, Werfen USA LLC will provide two fully automated, discrete, random access...
- This is a firm fixed price delivery order contract awarded by the Defense Health Agency to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The contract, valued at $410,528.40, is for the delivery of coagulation tests and has a period of performance through March 31, 2024. The contract was issued under the GSA Schedule 66-III for Critical Analyzers and Laboratory Equipment, with no set-aside designation. Werfen USA LLC has existing Blanket Purchase...
- This federal contract award to Werfen USA LLC is for the provision of coagulation analyzers to the Defense Health Agency, a defense agency. The contract is a delivery order issued under the General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) schedule contract, with a firm fixed-price of $83,257.80 and a period of performance ending on September 30, 2025. The contract does not have a small business set-aside designation, indicating Werfen USA LLC is competing as a...
- The Department of the Air Force Materiel Command awarded a firm fixed price purchase order contract to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services, for the provision of Werfen coagulation analyzers, reagents, and consumables. The contract has a completion date of April 16, 2024 and a potential value of $120,329.40. This award is not associated with a set-aside designation. Werfen has supplied similar diagnostic equipment and testing services to federal...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $58,829.39 to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents. This firm fixed-price contract, which was not set aside for small businesses, was executed on August 6, 2025, with an ultimate completion date of the same day. The award represents a task order under Werfen's existing BPA vehicle with the Defense Health Agency for the supply of specialized...
The Defense Health Agency awarded a $714.7K firm fixed-price purchase order to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, for blood coagulation testing supplies and support services. This contract, which commenced on October 1, 2020, and extends through September 30, 2025, involves the delivery of two fully automated benchtop coagulation analyzer systems capable of performing comprehensive assays including prothrombin time, international normalized ratio, partial thromboplastin time, fibrinogen, heparin, anti-Xa, and D-dimer testing. The contractor's responsibilities encompass equipment delivery, installation, training, method validation, preventative maintenance, and emergency repair services. Pricing is structured on a cost-per-test basis reflective of estimated annual test volumes. The award carries no small business set-aside designation, allowing Werfen to compete as a full-sized contractor. Werfen USA LLC maintains an established relationship with federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency, with a portfolio of specialized laboratory equipment supply contracts and Blanket Purchase Agreements. The company holds multiple Indefinite Delivery/Indefinite Quantity contracts and GSA Schedule positions under categories including Critical Analyzers, Laboratory and In Vitro Diagnostics, Reagents, and Test vehicles, positioning it as a key provider of sophisticated medical diagnostic products and services to federal healthcare systems.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Blood Coagulation Testing Supplies | W81K0020Q0124 | Department of the Army Medical Command | Award Notice 2/2 | 9/29/20, 2:53 PM | |
Blood Coagulation Testing Supplies | PANHCA20P0000005539 | Department of the Army Medical Command | Solicitation 1/2 | 8/19/20, 1:36 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00013 | Funding Only Action | ($35k) | 8/8/25 | |
| P00012 | Funding Only Action | $156.9k | 11/22/24 | |
| P00011 | Exercise an Option | $0 | 5/31/24 | |
| P00010 | Funding Only Action | $1.0k | 11/29/23 | |
| P00009 | Funding Only Action | $155.9k | 10/25/23 |